Day One Biopharmaceuticals Inc DAWN:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/03/23 EST
21.15quote price arrow up+0.04 (+0.19%)
Volume
13,936
Close
21.11quote price arrow down-0.64 (-2.94%)
Volume
420,313
52 week range
5.44 - 28.35
Loading...
  • Open21.30
  • Day High21.98
  • Day Low20.92
  • Prev Close21.75
  • 52 Week High28.35
  • 52 Week High Date08/12/22
  • 52 Week Low5.44
  • 52 Week Low Date05/27/22

Key Stats

  • Market Cap1.553B
  • Shares Out73.55M
  • 10 Day Average Volume0.45M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-1.91

KEY STATS

  • Open21.30
  • Day High21.98
  • Day Low20.92
  • Prev Close21.75
  • 52 Week High28.35
  • 52 Week High Date08/12/22
  • 52 Week Low5.44
  • 52 Week Low Date05/27/22
  • Market Cap1.553B
  • Shares Out73.55M
  • 10 Day Average Volume0.45M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-1.91

RATIOS/PROFITABILITY

  • EPS (TTM)-1.96
  • P/E (TTM)-10.76
  • Fwd P/E (NTM)-9.18
  • EBITDA (TTM)-126.088M
  • ROE (TTM)-37.54%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date03/07/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Day One Biopharmaceuticals Inc

 

Profile

MORE
Day One Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing targeted therapies for patients of all ages with genomically-defined cancers. It seeks to identify, acquires, and develops product candidates that target high-value oncogenic drivers in cancers with unmet need, with an initial focus on pediatric patients. Its lead product candidate, DAY101 (tovorafenib), is an oral, brain-penetrant, highly selective...
Garry Nicholson
Chairman of the Board
Jeremy Bender Ph.D.
President, Chief Executive Officer, Director
Charles York II
Chief Financial Officer, Chief Operating Officer, Secretary
Address
2000 Sierra Point Parkway, Suite 501
Brisbane, CA
94080-1930
United States